All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ELICIO THERAPEUTICS, INC. Last Reported: 1/31/2024 Stock Symbol: ELTX

Business Address

451 D STREET, 5TH FLOOR

BOSTON , MA US 02210

Mailing Address

451 D STREET, 5TH FLOOR

BOSTON , MA US 02210
Phone Number: (857) 209-0050 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 6/30/2023 5/31/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 1/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $21,682,000.00 -- $55,143,000.00 $63,372,000.00 $88,756,000.00 $102,736,000.00 $117,300,000.00 $130,500,000.00 -- $34,607,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,543,000.00 -- $1,537,000.00 $2,513,000.00 $1,685,000.00 $1,657,000.00 $2,389,000.00 $3,042,000.00 -- $7,690,000.00 -- -- -- --
Total Current Assets $26,225,000.00 -- $56,680,000.00 $65,885,000.00 $91,247,000.00 $104,393,000.00 $119,702,000.00 $133,498,000.00 -- $42,297,000.00 -- -- -- --
Property Plant and Equipement $919,000.00 -- $304,000.00 $388,000.00 $451,000.00 $475,000.00 $412,000.00 $246,000.00 -- $156,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- $75,000.00 $86,000.00 $106,000.00 $33,000.00 $38,000.00 $38,000.00 -- -- -- -- -- --
Total Assets $37,619,000.00 -- $61,316,000.00 $70,813,000.00 $96,513,000.00 $109,940,000.00 $125,359,000.00 $139,200,000.00 -- $47,347,000.00 -- -- -- --
Accounts Payable $4,265,000.00 -- $2,218,000.00 $2,656,000.00 $4,710,000.00 $7,679,000.00 $9,307,000.00 $6,690,000.00 -- $5,578,000.00 -- -- -- --
Accrued Liabilities $2,315,000.00 -- $4,908,000.00 $4,086,000.00 $3,219,000.00 $5,349,000.00 $4,675,000.00 $4,092,000.00 -- $6,665,000.00 -- -- -- --
Total Current Liabilities $14,062,000.00 -- $11,106,000.00 $11,053,000.00 $15,006,000.00 $45,426,000.00 $48,170,000.00 $46,757,000.00 -- $137,796,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-2,000.00 -- $302,000.00 $98,000.00 $-103,000.00 $-73,000.00 $-219,000.00 $-287,000.00 -- $-333,000.00 -- -- -- --
Accumulated Deficit $-122,600,000.00 -- $-247,502,000.00 $-238,500,000.00 $-215,100,000.00 $-230,000,000.00 $-214,321,000.00 $-197,200,000.00 -- $-160,562,000.00 -- -- -- --
Total Stockholders' Equity $23,557,000.00 -- $50,210,000.00 $59,760,000.00 $81,507,000.00 $64,514,000.00 $77,189,000.00 $92,443,000.00 -- $-90,449,000.00 $-63,192,000.00 $-49,097,000.00 $-30,676,000.00 $-18,586,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $37,619,000.00 -- $61,316,000.00 $70,813,000.00 $96,513,000.00 $109,940,000.00 $125,359,000.00 $139,200,000.00 -- $47,347,000.00 -- -- -- --

Statement of Operations

Date 6/30/2023 5/31/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 1/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- $2,301,000.00 $28,312,000.00 $1,460,000.00 $911,000.00 $371,000.00 -- -- $2,421,000.00 $729,000.00 $865,000.00 --
Cost of Revenues -- -- -- -- $433,000.00 -- -- -- -- -- $1,064,000.00 $716,000.00 $383,000.00 --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $4,944,000.00 -- $2,938,000.00 $17,740,000.00 $48,698,000.00 $42,030,000.00 $28,742,000.00 $14,298,000.00 -- -- $27,912,000.00 $12,230,000.00 $9,596,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-7,777,000.00 -- $-9,050,000.00 $-23,520,000.00 $-39,307,000.00 $-53,941,000.00 $-38,183,000.00 $-19,939,000.00 -- -- $-11,585,000.00 $-29,838,000.00 $-12,569,000.00 --
Loss Before Income Taxes -- -- -- -- $-54,573,000.00 -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-2.44 -- $-1.08 $-0.78 $-1.93 $-2.51 $-2.02 $-1.56 -- -- $-1.19 $-2.32 $-0.91 --
Weighted Average Shares Basic 1,720,202 -- 30,113,407 29,966,609 28,244,825 27,671,310 29,670,329 23,443,851 -- -- 14,847,534 14,488,746 14,462,823 --
Earnings Per Share Diluted $-9.06 -- $-0.30 $-0.30 $-1.93 $-0.53 $-2.02 $-1.56 -- -- $-3.51 $-2.32 $-0.91 --
Weighted Average Shares Diluted 3,100,957 9,700,000 30,113,407 29,973,886 28,244,825 29,829,577 26,574,290 23,443,851 -- -- 14,847,534 14,514,670 14,462,823 --
Common Stock Shares Authorized 300,000,000 -- -- 300,000,000 30,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 -- -- -- --
Common Stock Shares Outstanding 8,370,268 8,387,025 30,113,582 30,052,544 29,959,060 29,933,095 29,797,587 29,660,458 -- 15,316,721 -- -- -- --
Common Stock Value $84,000.00 -- $301,000.00 $301,000.00 $300,000.00 $304,000.00 $303,000.00 $300,000.00 -- $156,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.01 -- $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 -- -- -- -- -- -- -- 10,000,000 -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.01 -- -- -- -- -- -- -- $0.01 -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com